327 related articles for article (PubMed ID: 14668072)
21. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
Kozlowski LT
Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
[TBL] [Abstract][Full Text] [Related]
22. Tobacco-specific nitrosamines in new tobacco products.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2006 Apr; 8(2):309-13. PubMed ID: 16766423
[TBL] [Abstract][Full Text] [Related]
23. Unintentional child poisonings through ingestion of conventional and novel tobacco products.
Connolly GN; Richter P; Aleguas A; Pechacek TF; Stanfill SB; Alpert HR
Pediatrics; 2010 May; 125(5):896-9. PubMed ID: 20403932
[TBL] [Abstract][Full Text] [Related]
24. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
[TBL] [Abstract][Full Text] [Related]
25. Assessing the nicotine content of smokeless tobacco products.
Tilashalski K; Rodu B; Mayfield C
J Am Dent Assoc; 1994 May; 125(5):590-2, 594. PubMed ID: 8195501
[TBL] [Abstract][Full Text] [Related]
26. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives.
Baker RR; Pereira da Silva JR; Smith G
Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836
[TBL] [Abstract][Full Text] [Related]
27. Free-base nicotine in tobacco products. Part II. Determination of free-base nicotine in the aqueous extracts of smokeless tobacco products and the relevance of these findings to product design parameters.
Lauterbach JH; Bao M; Joza PJ; Rickert WS
Regul Toxicol Pharmacol; 2011 Feb; 59(1):8-18. PubMed ID: 20849905
[TBL] [Abstract][Full Text] [Related]
28. From the Centers for Disease Control and Prevention. Determination of nicotine, pH, and moisture content of six US commercial moist snuff products--Florida, January-February 1999.
JAMA; 1999 Jun 23-30; 281(24):2279-80. PubMed ID: 10386544
[No Abstract] [Full Text] [Related]
29. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
30. The influence of pH and nicotine concentration in oral moist snuff on mucosal changes and salivary pH in Swedish snuff users.
Andersson G; Warfvinge G
Swed Dent J; 2003; 27(2):67-75. PubMed ID: 12856395
[TBL] [Abstract][Full Text] [Related]
31. The legal and scientific basis for FDA's assertion of jurisdiction over cigarettes and smokeless tobacco.
Kessler DA; Barnett PS; Witt A; Zeller MR; Mande JR; Schultz WB
JAMA; 1997 Feb; 277(5):405-9. PubMed ID: 9010173
[TBL] [Abstract][Full Text] [Related]
32. Nicotine content and delivery across tobacco products.
Djordjevic MV; Doran KA
Handb Exp Pharmacol; 2009; (192):61-82. PubMed ID: 19184646
[TBL] [Abstract][Full Text] [Related]
33. In vitro study of nicotine release from smokeless tobacco.
Nasr MM; Reepmeyer JC; Tang Y
J AOAC Int; 1998; 81(3):540-3. PubMed ID: 9606918
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive chemical characterization of Rapé tobacco products: Nicotine, un-ionized nicotine, tobacco-specific N'-nitrosamines, polycyclic aromatic hydrocarbons, and flavor constituents.
Stanfill SB; Oliveira da Silva AL; Lisko JG; Lawler TS; Kuklenyik P; Tyx RE; Peuchen EH; Richter P; Watson CH
Food Chem Toxicol; 2015 Aug; 82():50-8. PubMed ID: 25934468
[TBL] [Abstract][Full Text] [Related]
35. A qualitative and quantitative risk assessment of snuff dipping.
Nilsson R
Regul Toxicol Pharmacol; 1998 Aug; 28(1):1-16. PubMed ID: 9784428
[TBL] [Abstract][Full Text] [Related]
36. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
[TBL] [Abstract][Full Text] [Related]
37. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
Parascandola M
Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
[TBL] [Abstract][Full Text] [Related]
38. Chemical analysis of snus products from the United States and northern Europe.
Lawler TS; Stanfill SB; Tran HT; Lee GE; Chen PX; Kimbrell JB; Lisko JG; Fernandez C; Caudill SP; deCastro BR; Watson CH
PLoS One; 2020; 15(1):e0227837. PubMed ID: 31940415
[TBL] [Abstract][Full Text] [Related]
39. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of the mutagenicity of various types of tobacco products.
Rickert WS; Wright WG; Trivedi AH; Momin RA; Lauterbach JH
Regul Toxicol Pharmacol; 2007 Aug; 48(3):320-30. PubMed ID: 17614170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
